Diisocyanates in polyurethane plastics applications

Occupational Medicine - State of the Art Reviews

Volumn 14, Issue 4, 1999, Pages 759-776

  Klees, Julia E ^a   Ott, M Gerald ^a  

^a BASF CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOCYANIC ACID DERIVATIVE; POLYURETHAN;

CHEMICALLY INDUCED DISORDER; HUMAN; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; RESPIRATORY TRACT DISEASE; REVIEW;

HUMANS; ISOCYANATES; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; POLYURETHANES; RESPIRATORY TRACT DISEASES;

EID: 33749201825     PISSN: 0885114X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Ulrich H: Urethane polymers. In Grayson M, Eckroth D (eds): Kirk-Othmer Concise Encyclopedia of Chemical Technology, 3rd ed. New York, John Wiley & Sons, 1985, pp 1211-1212.
2. American Conference of Governmental Industrial Hygienists: Threshold Limit Values and Biological Exposure Indices. Cincinnati, ACGIH, 1996, pp 1581-1589.
3. Levine SP, Hillig KJD, Dharmarajan V, et al: Critical review of methods of sampling, analysis, and monitoring for TDI and MDI. Am Ind Hyg Assoc J 56:581-589, 1995.
4. Chinn H, Cox WE, Ishikawa-Yamaki M: Diisocyanates and polyisocyanates. Chemical Economics Handbook. SRI International. September, 1998, pp 666.5000A-666.5003A.
5. Rosenberg C: Production and uses of polyurethanes (including thermodegradation). In Jarvisalo J, Pfaffli P, Vainio H (eds): Industrial Hazards of Plastics and Synthetic Elastomers. Progress in Clinical and Biological Research, Vol. 141. New York, Alan R. Liss, 1984, pp 337-346.
6. Henschler D, Assmann W, Meyer KO: Zur Toxikologie der Toluylendiisocyanate [On the toxicology of toluene diisocyanate]. Arch Toxikol 19:364-387, 1962.
7. Skarping G, Dalene M, Lind P: Determination of toluenediamine isomers by capillary gas chromatography and chemcial ionization mass spectrometry with special reference to the biological monitoring of 2,4- and 2,6-toluene diisocyanate. J Chromatogr 663:199-210, 1994.
8. Skarping G, Dalene M, Littorin M: 4,4′-Methylenedianiline in hydrolysed serum and urine from a worker exposed to thermal degradation products of methylene diphenyl diisocyanate elastomers. Int Arch Occup Environ Health 67:73-77, 1995.
9. Sepai O, Schütze D, Heinrich U, et al: Hemoglobin adducts and urine metabolites of 4,4′-methylenedianiline after 4,4′-methylenediphenyl diisocyanate exposure of rats. Chemico-Biological Interactions 97:185-198, 1995.
10. Skarping G, Dalene M, Svenssen B-G, et al: Biomarkers of exposure, antibodies, and respiratory symptoms in workers heating polyurethane glue. Occup Environ Med 53:180-187, 1996.
11. Lushniak BD, Reh CM, Bernstein DI, Gallagher JS: Indirect assessment of 4,4′-diphenylmethane diisocyanate (MDI) exposure by evaluation of specific humoral immune responses to MDI conjugated to human serum albumin. Am J Ind Med 33:471-477, 1998.
12. American Conference of Governmental Industrial Hygienists. Documentation of the Threshold Limit Values and Biological Exposure Indices. 5th ed. Cincinnati, ACGIH, 1986, pp 580-585.
13. Walworth HT, Virchow WE: Industrial hygiene experiences with TDI. Am Ind Hyg Assoc J 20:205-210, 1959.
14. Woolrich P: Toxicology, industrial hygiene and medical control of TDI, MDI and PMPPI. Am Ind Hyg Assoc J 43:89-97, 1982.
15. Vandenplas O, Malo JL, Dugas M, et al: Hypersensitivity pnuemonitis-like reaction among workers exposed to diphenylmethane diisocyanate (MDI). Am Rev Respir Dis 147:338-346, 1993.
16. Baur X: Hypersensitivity pneumonitis (extrinsic allergic alveolitis) induced by isocyanates. J Allergy Clin Immunol 95:1004-1010, 1995.
17. Simpson C, Garabrant D, Torrey S, et al: Hypersensitivity pneumonitis-like reaction and occupational asthma associated with 1,3-bis(isocyanatomethyl)cyclohexane pre-polymer. Am J Ind Med 30:48-55, 1996.
18. Raulf-Heimsoth M, Baur X: Pathomechanisms and pathophysiology of isocyanate-induced diseases - Summary of present knowledge. Am J Ind Med 34:137-143, 1998.
19. Meredith SK, Taylor VM, McDonald JC: Occupational respiratory disease in the United Kingdom 1989: A report to the British Thoracic Society and the Society of Occupational Medicine by the SWORD project group. Br J Ind Med 48:292-298, 1991.
20. Ross DJ, Sallie BA, McDonald JC: SWORD '94: Surveillance of work-related and occupational respiratory disease in the UK. Occup Med 45:175-178, 1995.
21. Straßburger KU, Will W, Zober A: Allergisches Berufsasthma (BK-Nr. 4301) in Deutschland [Allergic occupational asthma in Germany]. Auswertung der Berufskrankheiten-Dokumentationsdaten 1989-1993 [Evaluation of occupational disease documentation data, 1989-1993]. Arbeitsmed, Sozialmed Umweltmed 31:461-467, 1996.
22. Rosenman KD, Reilly MJ, Kalinowski DJ: A state-based surveillance system for work-related asthma. J Occup Environ Med 39:415-425, 1997.
23. Weill H, Butcher B, Dharmarajan V, et al: Respiratory and immunologic evaluation of isocyanate exposure in a new manufacturing plant. U.S. Dept. Health and Human Services (NIOSH) Publication No. 81-125, U.S. Government Printing Office, Washington, D.C., 1981.
24. Diem JE, Jones RN, Hendrick DJ, et al: Five-year longitudinal study of workers employed in a new toluene diisocyanate manufacturing plant. Am Rev Respir Dis 126(3):420-428, 1982.
25. Clark RL, Bugler J, McDermott M, et al: An epidemiology study of lung function changes of toluene diisocyanale foamworkers in the United Kingdom. Int Arch Occup Environ Health 71:169-179, 1998.
26. Jones RN, Rando RJ, Glindmeyer HW, et al: Abnormal lung function in polyurethane foam producers. Am Rev Respir Dis 146:871-877, 1992.
27. Woellner RC, Hall S, Greaves I, Schoenwetter WF: Epidemic of asthma in a wood products plant using methylene diphenyl diisocyanate. Am J Ind Med 31:56-63, 1997.
28. Paggiaro PL, Vagaggini B, Bacci E, et al: Prognosis of occupational asthma. Eur Respir J 7:761-767, 1994.
29. Carino M, Aliani M, Licitra C, et al: Death due to asthma at workplace in a diphenylmethane diisocyanate-sensitized subject. Respiration 64:111-113, 1997.
30. Pisati G, Baruffini A, Zedda S: Toluene diisocyanate induced asthma: Outcome according to persistence or cessation of exposure. Br J Ind Med 50:60-64, 1993.
31. Park HS, Nahm DH: Prognostic factors for toluene diisocyanate-induced occupational asthma after removal from exposure. Clin Exp Allergy 27:1145-1150, 1997.
32. Tarlo SM, Banks D, Liss G, Broder I: Outcome determinants for isocyanate induced occupational asthma among compensation claimants. Occup Environ Med 54:756-761, 1997.
33. Peters JM, Murphy RLH, Pagnotto LD, Whittenberger JL: Respiratory impairment in workers exposed to "safe" levels of toluene diisocyanate (TDI). Arch Environ Health 20:364-367, 1970.
34. Adams WGF: Long-term effects on the health of men engaged in the manufacture of tolylene diisocyanate. Br J Ind Med 32:72-78, 1975.
35. Garabrant DH, Levine SH: A critical review of the methods of exposure assessment and the pulmonary effects of TDI and MDI in epidemiologic studies. International Isocyanate Institute, 1994.
36. Tornling G, Alexandersson R, Hedenstierna G, Plate N: Decreased lung function and exposure to diisocyanates (HDI and HDI-BT) in car repair painters: Observations on re-examination 6 years after initial study. Am J Ind Med 17:299-310, 1990.
37. Sorahan T, Pope D: Mortality and cancer morbidity of production workers in the United Kingdom flexible polyurethane foam industry. Br J Ind Med 50:528-536, 1993.
38. Hagmar L, Welinder H, Mikoczy Z: Cancer incidence and mortality in the Swedish polyurethane foam manufacturing industry. Br J Ind Med 50:537-543, 1993.
39. Hagmar L, Strömberg U, Welinder H, Mikoczy Z: Incidence of cancer and exposure to toluene diisocyanate and methylene diphenyldiisocyanate: A cohort based case-referent study in the polyurethane foam manufacturing industry. Br J Ind Med 50:1003-1007, 1993.
40. Schnorr TM, Steenland K, Egeland GM, et al: Mortality of workers exposed to toluene diisocyanate in the polyurethane foam industry. Occup Environ Med 53:703-707, 1996.
41. National Institute for Occupational Safety and Health (NIOSH). NIOSH Alert: Request for assistance in preventing asthma and death from diisocyanate exposure. DHHS (NIOSH) Publication No. 96-111. 1996.
42. Klees JE, Alexander M, Rempel D, et al: Evaluation of a proposed NIOSH surveillance case definition for occupational asthma. Chest 98(5 suppl):212S-215S, 1990
43. Bernstein DI, Korbee L, Stauder T, et al: The low prevalence of occupational asthma and antibody dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to diisocyanates. J Allergy Clin Immunol 92:387-396, 1993.
44. Comstock GW, Tockman MS, Helsing KJ, Hennesy KM: Standardized respiratory questionnaires: Comparison of the old with the new. Am Rev Respir Dis 119:45-53, 1979.
45. British Rubber Manufacturers' Association: Toxicity and safe handling of diisocyanates and ancillary chemicals: A code of practice for polyurethane flexible foam manufacture. Hull (UK), White & Farrell, 1989.
46. Venables KM, Farrer N, Sharp L, et al: Respiratory symptoms questionnaire for astham epidemiology: Validity and reproducibility. Thorax 48:214-219, 1993. Comments: Letters to the editor. Thorax 48. 1993 - Donoghue AM, p 871; McKinlay KP, Venables KM, p 1289.
47. Chan-Yeung M: Asthma. In Rosenstock L, Cullen MR (eds): Textbook of Clinical Occupational and Environmental Medicine. Philadelphia, WB Saunders, 1997, pp 197-209.
48. Burge PS: Use of serial measurements of peak flow in the diagnosis of occupational asthma. Occup Med State Art Rev 8:279-294, 1993.
49. Hankinson JL, Das MK: Frequency response of portable PEF meters. Am J Respir Crit Care Med 152(2):702-706, 1995.
50. Koyama H, Nishimura K, Ikeda A, et al: Comparison of four types of portable peak flow meters (Mini-Wright, Assess, Pulmo-graph and Wright Pocket meters). Respir Med 92(3):505-511, 1998.
51. Grammer L, Patterson R: Immunologic evaluation of occupational asthma. In Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI (eds): Asthma in the Workplace. New York, Marcel Dekker, 1993, p 125.
52. Chan-Yeung M. Nonspecific broncial hyperresponsiveness. In Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI (eds): Asthma in the Workplace. New York, Marcel Dekker, 1993, p 207.
53. Bernstein DI: A guide for the primary care physician in evaluating diisocyanate exposed workers for occupational asthma. International Isocyanate Institute, 1988.
54. Kraw M, Tarlo SM: Isocyanate medical surveillance: Respiratory referrals from a foam manufacturing plant over a five-year period. Am J Ind Med 35:87-91, 1999.
55. Malo JL, Ghezzo H, L'Archeveque J, et al: Is the clinical history a satisfactory means of diagnosing occupational asthma? Am Rev Respir Dis 143:528-532, 1991.
56. Perrin B, Cartier A, Ghezzo H, et al: Reassessment of the temporal patterns of bronchial obstruction after exposure to occupational sensitizing agents. J Allergy Clin Immunol 87:630-639, 1991.
57. Cartier A, Malo JL: Occupational challenge tests. In Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI (eds): Asthma in the Workplace. New York, Marcel Dekker, 1993, pp 215-247.
58. Burge PS, O'Brien IM, Harries MG: Peak flow rate records in the diagnosis of occupational asthma due to isocyanates. Thorax 34:317-323, 1979.
59. Venables KM, Burge PS, Davison AG, Newman Taylor AJ: Peak flow rate records in surveys: Reproducibility of observers' reports. Thorax 39:828-832, 1984.
60. Chan-Yeung M: Nonspecific bronchial hyperresponsiveness. In Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI (eds): Asthma in the Workplace. New York, Marcel Dekker, 1993, pp 198-214.
61. Durham SR, Graneek BJ, Hawkins R, Taylor AJ: The temporal relationship between increases in airway hyperresponsiveness to histamine and late asthmatic responses induced by occupational asthma. J Allergy Clin Immunol 79:398-406, 1987.
62. DeGroot AC: Patch Testing: Test Concentration and Vehicles for 3700 Chemicals. 2nd ed. Amsterdam, Elsevier, 1994, pp 179, 263.